‘I Can Still Do That Foundation’ & Tom Pacheco Premiere “Freida’s Secret Garden”

Shot in Humboldt County, the video uses local talent and filmmakers to promote cannabis legalization

NEW YORK: The I Can Still Do That Foundation, a New York City-based non-profit whose mission is to connect people so they can share information and empower each generation to teach the others, launched “Freida’s Secret Garden “  a pro-pot music video based on a song by legendary Woodstock singer-songwriter Tom Pacheco.

“The time to end irrational prohibition of cannabis is now,’  Dan Schneider, Executive Director of the Foundation, announced. “With 33 States now recognizing the benefits of medical cannabis and another 11 States legalizing recreational cannabis, a majority of Americans are in favor of legalization and the end of the irrational and Draconian laws which have stifled research on the potential benefits of cannabis. These laws have had a disparate impact on people of color and restoration of civil rights to those who have been adversely affected is also required to promote equity. The patchwork of irrational and inconsistent federal and state laws must end and the federal law must allow these now legal business to access the federal banking system to that black market producers of questionable products can be replaced by healthy and tested, legal cannabis and CBD products.”

“We want to thank advisor Lelehnia DuBois and her friends in the Humboldt County for helping us make the new music video,” Schneider said. “You can see the new video here in a sneak peek. Please share it with friends. We are trying to help Tom get the recognition he deserves as a legendary singer/songwriter who has written songs for Bob Dylan, The Band, Jefferson Starship, and others. He has a music publishing catalogue of more than 500 songs; “Freida’s” is just one of many great ones.

Still Do That advisor, Curved Papers Founder Michael O’Malley, said, “This song and video bring together the West Coast and East Coast hippie vibes – from Humboldt County to Woodstock – that have given rise to the contemporary cannabis legalization movement. Call it Cannafest Destiny. The fun, the healing compassion and sensible restoration of marijuana’s rightful place in society are all captured humorously in Tom’s lyric and rocking rhythm.

David Rheins, founder of the Marijuana Business Association and Still Do That Advisor agreed: “Marijuana has gone mainstream, and the mainstream media is now getting hip to the power of the plant and the amazing possibilities that legalization brings.  Through the work of artists and activists like  Tom Pacheco,  we are raising cannabis consciousness, and dispelling the dangerous myths and harmful policies of prohibition.”

Still Do That Advisor Melissa Gibson, founder of Hemp and Humanity said, “This folksy and campy musical send-up to the authentic cannabis lifestyle pays homage to the plant, place and people who have championed it for generations. As marijuana use reaches a tipping point in mainstream acceptance, and the cannabis industry has attracted big business, Tom Pacheco take us back to the root(s) of this plant and its essential spirit of connecting humans with one another. What Frieda and her happy, hippy grandson Paul know, is that cannabis has the power to heal, clothe, feed, house, fuel and sustain human’s ability to live on this earth. And that’s worth singing about.”

Still Do That Advisor Lelehnia DuBois, cannabis community advocate and Sensi Magazine publisher, who co-produced the video and played the title role of Freida added, “I come from a culture of Frieda’s. It felt like she was my own mother. It was an honor to play the role”

According to Schneider, an entertainment lawyer by trade, the Foundation plans to produce a weekly TV news series called, “High Hopes”,  to educate people on the history, legal issues, health issues, science and finance surrounding the booming legal cannabis industry.  “We may even use Tom Pacheco’s song as a theme song for our TV series,” Schneider said. “We are currently looking for partners and sponsors for the series and are particularly interested in pro-cannabis celebrities to help demystify the stigma surrounding cannabis.”

MJBA Founder David Rheins Picks The Hottest Hemp, CBD, Vape & Culture+ Products Of 2019 At ASD Market Week | Culture+

VIP Panel Will Include Founders of Elixinol, The Blinc Group, Curved Papers and Farmer Tom Hemp Co.

NEVADA: The Culture+ marketplace is exploding, with thousands of new legal hemp, CBD, vape and cannabis-culture products creating consumer excitement and marketplace disruption.

MJBA at ASD

MJBA’s founder and executive director David Rheins, a seasoned marketing executive who learned his chops playing senior roles for Rolling Stone, SPIN, Time Warner AOL, has scoured the country to find The Hottest Hemp, CBD & Culture+ Products of 2019, which he’ll present at the ASD Market Week | Culture+ convention in Las Vegas on Monday, March 18, 9:00 AM – 9:45 AM.

Screenshot 2018-12-10 16.46.33These are the products that every retailer must know about – from hemp-based fashions and CBD health and beauty aids, to the latest in vaporizer technology and glassware.

Screenshot 2018-12-10 14.26.21

Following the 45-minute presentation, moderator David Rheins will lead a VIP Panel Discussion with the brand marketers who are building the industries best and most innovative brands, including Elixinol co-founder David Newman, The Blinc Group CEO Sasha Aksenov, Farmer Tom Hemp Co. Founder Tom Lauerman, and Curved Papers Founder Michael O’Malley.

Hemp is projected to be a $22 Billion market by 2012. Get an advanced look at all the hottest products, trends and technologies driving the red-hot Culture+ market.

Registration for the show is available online.

Marketing Thru Marijuana: Differentiate or Die

This is the year that hippie cannabis dies. Woodstock is 50, and has just licensed its name to mega-retailer MedMen.  Hemp is newly de-scheduled and igniting the imaginations of farmers and investors excited about the global opportunity.  Pot Culture has become Pop Culture as legalization has spread coast-to-coast and pushed marijuana into the mainstream.

For grassroots marketers who have been playing in our fragmented American marketplace — where no two states share identical regulations or standards — things have gotten tough in the last year as legal competition from Big Pharma, Big Alcohol, Big Tobacco, Big Consumer Package Goods and Big Agriculture have transformed the playing field.

“As our nascent industry rockets from grassroots to global, it’s Differentiate or Die time for independent companies hoping to stay relevant in an increasingly noisy landscape.” MJBA Founder and veteran marketer David Rheins told MJNews Network.

“You must be able to stand out from the cacophony.  My advice for the licensed cannabis business and ancillary provider alike, is to focus on defining your brand differentiation.  Find a niche, fill a niche.  Your competition moving forward is Big Industry, which has the money, the technology and the wherewithal to take a product from field or factory to shelf better than the little guy ever will.”

His advice: Build your brand authority.  “Big Industry doesn’t understand emerging markets — who the consumer are, their buying preferences and psychographics,” Rheins said.  “As a small business, you are part of the community. You are making a market — defining the industry and your space in it.  No one understands its needs and attitudes of the new market better than the grassroots marketer.  Build your brand around your values, and the values of your customers and your community.   Establish brand loyalty and authority — with your vendors, and your customers, wether you are b2b or b2c — by lending value.”

Differentiate Or Die

Rheins suggests that the New Year is a good time for all marketers to do a brand review.  As an exercise, he encourages his clients to ask their investors, employees, vendors and customers to answer a couple of questions:

1) Describe our brand value  — what do we stand for — in one sentence.

2) What products/services do we offer.

3) What is our unique selling proposition (USP) — what do we do better than other brands?

“You’d be surprised how much intelligence you’ll gain just by analyzing these questions,” Rheins said.  “It only goes to reinforce that today marketing is not simply an exercise of spending money on paid advertising.  Advertising — particularly targeted placements — can be effective, but savvy marketers today depend on an integrated strategy that includes owned media (your company websites and newsletters) and earned media — social media engagement on public platforms with business communities and groups on Facebook, Twitter, Instagram, Reddit.

In this dynamic environment, Rheins advises businesses to stay engaged and stay fresh.

Take An Annual Brand Checkup

1) Do A Brand Review: How well do your customers understand your Brand Values and USP? How well do you understand your customer segments?

2) Website Audit: How fresh is your content? Are you SEO optimized? Are you using your website to gather customer feedback?

3) Social Media Audit: How visible is your brand on key social media platforms?  How often do you post content?  How quickly do you respond to queries or brand mentions? Who in your company is responsible for social media?

4) Community Check Up: How engaged is your brand in your community — not just your cannabis community but your local community?  Do you sponsor local events? Do you give to local charities? How well liked is your brand on Main Street?

 

 

MJNews Exclusive Interview With Saul Kaye, CEO/Founder iCAN: Israel Cannabis

Since the 1960s, Israel has led the world in medical cannabis research. Now, as international markets emerge for legal medical cannabis, the country is poised to become a major global player.  Recently, the Israeli Parliament caused a great deal of industry excitement when it passed a bill that would pave the way for Israel to become an exporter of both cannabis flower and, perhaps more significantly, the intellectual property and data from its seminal research and clinical trials.

For the past five years, iCAN: Israel Cannabis and its CannaTech conferences have been instrumental in shaping the Israel medical cannabis landscape.  In this exclusive interview held on New Year’s Eve, MJNews’ editor David Rheins talked to iCAN CEO and Founder Saul Kaye.  The interview is now live on MJChannelOne.

Saul Kaye:         My name is Saul Kaye. I’m the CEO and founder of iCAN: Israel Cannabis. We’re ecosystem builders. We started in the cannabis space in Israel about five years ago and help to build a new way of talking around cannabis and how to approach this both as a medicine and an industry and had some success around the world. And today we primarily go to governments, go to the industry and find synergies between various companies, incubate great ideas in the cannabis space and put on awesome events that educate people about cannabis and the wonders of cannabis medicine and how it’s going to change the world.

MJNews:          So, we’re at some auspicious news here at the end of 2018. The Israeli Parliament has just passed an export law — can you share with us what that means? What are the prospects for the prime minister signing that into law and what does that portend for us in the coming months?

Saul Kaye:         Sure. So it’s another step in a long process that’s been going on for a long time. It’s not the end of the process. It’s not that tomorrow we can export, but the Knesset, our ruling parliament at the time, before it was just the dissolved, said we unanimously want export to happen. Now it’s the policy’s job to go and make that happen. So, the last thing that has to happen is Bibi has to sign it into law. But now there is no, you know… the focus is maybe on getting reelected. I don’t know if that’s going to happen before the coming elections or whether we’re going to have to wait. I think cannabis is going to be a major issue in the upcoming election. So right now, what does it mean? It means there is a desire from our cabinet, from our legislature to make sure that export does happen.

iCAN | Israel Cannabis

Saul Kaye:         I don’t think we’re going to go backwards and have to revisit that. There’s a clear desire that Israel continue to be a leader in this industry. And I think that it’s now just a matter of playing out the end of the chess game: having everything signed and sealed, and then export will happen.  At the same time, you have to remember that the companies here in Israel and not scaled up yet for export.  You know, we’ve all been waiting to see how it’s going to play out. Lots of promises from the side of the government and it took her time, but I think that’s going to give these companies now an opportunity to begin scaling for the massive demand that exists overseas.

MJNews:          It’s fascinating. the Israeli approach to medical cannabis has been an almost 180 degree opposite approach to what we see here in the United States. Obviously, Israel was a pioneer back starting as early as the 1960s identifying THC and working to unlock the medical implications of cannabis, and you’ve approached it from a systemic point of view — meaning that we have Israeli hospitals and physicians and the medical establishment, if you will, working together on medical cannabis. Compare and contrast that with the US, which has had a patchwork of grassroots, assorted voter initiatives that have empowered cannabis entrepreneurs, but not really provided the infrastructure for medical research. How are those two systems coming together? And where does export fit in, and what exactly are we talking about in terms of export moving forward?

Saul Kaye:         So, you know, the first part to what’s unique and what’s worked about Israel is that we didn’t have the noise of the recreational market. We had a research focus to help the really sick, and it wasn’t easy to get. It’s really complicated, and you’ve got to be really ill to get it. So there are lots of holes we can poke in these Israeli system. It’s not perfect, but what it did do is say ‘Patient First,’ let’s give them some medicine and see what happens. And over time, helped to develop an infrastructure that allows for that and now it’s really moving into the new phase: what they promise of doctors being educated, pharmacists being educated, and it becoming just like another medication in the arsenal of the toolkit of doctors to use.  So that, you know, from a perspective of understanding both the regulator side, yes, it takes time to regulate this — to allow the stigma to dissolve.

Screenshot 2018-12-31 11.59.16

Saul Kaye:         Also, over time, we’ve seen more clinical trials that have proven that it works, and that it helps and that it is sometimes better than pharmaceuticals. And all of this has led to sort of a tipping point at this time where we can now all say… Well, you know, how come it didn’t happen 10 years ago?  Because we didn’t have the amount of information we have. So stigma was much stronger. So all of those things happened. And that’s what happened in Israel. And it’s one of the places where you’ve got two degrees of separation, sometimes even one degree of separation. So, if Professor Mechoulam, who is in Jerusalem, needs something that’s being done by Dr. Dedi Meir at the Technion — that’s a two-hour drive. Everyone knows everyone. We’re all family. Also, from a patient perspective, most people in Israel know a patient that has received medical cannabis for cancer.

It’s probably grandmother, or one of grandmother’s friends, and they’ve seen it helping and it’s been around a lot. So that singular focus of helping patients — even though there’s a bureaucratic nightmare in order to get it — has given Israel a leading edge. Now why do countries need Israeli cannabis? You know, from a US perspective, California doesn’t need Israeli cannabis. But as countries start to look at regulating cannabis, they are going to institute their own regulations. This will take six months to 12 months to write, then they are going put out a tender. Then everyone’s going to start. You’re talking two and a half years of no cannabis in the country as they begin to regulate. So what do you do with those patients that currently need cannabis  — that has been proven in Israel to work for epilepsy or for Crones, for Parkinson’s, you know, the things that we’re investigating here in Israel — and you get to a point where net exporters have a market for at least very short term, say one year to five years of entering new markets.

Saul Kaye:         And we also have knowledge both in growing cannabis, turning it into medicine, dosing and doing clinical trials.
That knowledge is something that we’re transferring overseas. So, we are both a net exporter of knowledge and a net exporter of cannabis product.

Screenshot 2018-12-31 11.58.28MJNews:          So, put some numbers to that. How big is the Israeli medical cannabis — physical cultivation, the physical production? How much cannabis is being produced in Israel?

Saul Kaye:         Uh, it’s a really good question. So, the, the old numbers before this whole new regulation came in, were eight [licensed] growers with a capacity to supply the market — at that stage, Israel had about 30,000 patients — around 10 to 12 tons. The new capacity of Israel is in the hundreds of thousands of tons. So that’s going somewhere. It’s not going to be diverted to the black market in Israel. It’s not going to be a play in Israel, it is all slated for Germany, the Czech Republic, Europe, Australia, et cetera. In in terms of money, what they’re saying that it’s $2Billion worth of industry in the next two years. In terms of numbers [moving forward], I’ve seen numbers up to $33Billion in the next five years. So, it’s a large thing.

MJNews:          The 33 Billion — that’s inclusive of intellectual property? Is IP really the big opportunity? I’ve been really excited about watching the progress in Israel of legitimate medical research. As you know, because of federal prohibition, while we have robust legal cannabis markets here in the States, and getting bigger and adding every day, that is changing, we really are behind the gun and so I’m looking at sort of the immediate opportunity, for the US? And quite honestly, our brothers to the north, the Canadians, are very aggressive as you know, because they have the public markets.  And they are investing in production, investing in IP. So, to what extent can the Israelis helped to jumpstart legitimate research here in North America? And then tell me why you’re looking at markets like Panama, for example, and, investing time and energy there.

Saul Kaye:         So, the first question, what does Israel offer to the big Canadian and US companies? Accelerated access to patients, to data. I can begin clinical trial very quickly in Israel. We very [closely monitor] our patients using cannabis, so we can see what that does for another condition. We’re an active, innovative startup nation. So, what we’re seeing in our startup world is quite differentiated for what I’m seeing at MJBizCon as an example. We’re really IP-driven tech companies — the same as we did in cyber security and the same as we did in the car automotive space. It needs so many other industries. We’re disrupting here as well. So, you know, my deal flow I think is better than what we’re seeing in the US. We’re not focusing here on ‘I’m a vertically integrated cannabis company and my specialty is I’m going to be a lifestyle brand.’  Well, that’s everyone. Oh, and ‘I’m going to be GMP.’ Can you imagine people going to a pharmaceutical conference, standing onstage and go, ‘I’m super proud. I’ve got GMP.’ We’re way beyond that conversation here in Israel. So yes, of course you need those standards, but yeah, we’re really going to disrupt this.

Screenshot 2018-12-31 11.58.13MJNews:          I want to thank you for all your time. I have a couple of last questions. Talk a little bit about standards, because it is something that plagues the industry. First of all, we’ve been spending most of our time this morning talking about medical cannabis, but, the implications for industrial hemp, for example, not to mention consumer package goods and all the implications of the recreational adult-use market — it’s a very wide horizontal opportunity with lots of segmentation in terms of the channels and the audiences. Tell me a little bit about those standards. You’re talking about GMP, which is something that has opened up international cannabis when it comes to medical, when it comes to defining those standards, how do activities and research in Israel sync up what’s going on, with folks at GW pharmaceuticals or what the FDA is looking at now with some relaxed and revised policies. Uh, how do we get agree upon common standards so we can all invest properly?

Saul Kaye:         So, you know, the government system here is what they call the five books — setting up nursery, cultivation, production, distribution and patient under separate licensing. Similar to vertical integration in Canada. Here in Israel, the focus has been that this is just like every other medicine. It is dispensed in pharmacies by a pharmacist. It is considered a narcotic. So we have no aspect of a recreational market. This is a serious medicine. You need to get serious doctors behind your treatment and your pharmacist to be involved in your treatment. So that’s how it’s playing out in Israel. So, it’s less of a recreational focus, but definitely more on the medical. So, the standards also, if you’ve got an immune compromised patient that’s taking an inhaled product of cannabis, we better be sure that it has no mold and pesticides.

Saul Kaye:         So, the standards for Pharma are just more rigid than the standards for cannabis as a food will have. It’s one standard: cannabis as a pharmaceutical. And that includes a standard of how you grow it, how you process it, how you clean it. And obviously packaging, distribution, security, all those things around cannabis. Those all need their regulations. What I can do as a company is to come in before government has regulated and help them get good regulation.  There’s a process that makes sense from an industry perspective and a security perspective. Remember the two most important things we want to do is make sure that there’s no diversion — there were not supporting the black market — and make sure that the quality is good. And if we do that, then the black market disappears and we get good cannabis regulations. And so we as a company come in to try and help governments do that.

saul kaye and david rheinsMJNews:          Fantastic. Here we are at New Year’s Eve. What are your predictions for 2019? What will medical cannabis in Israel look like 12 months from today?

Saul Kaye:         That’s a good question. I hope that we’ve doubled our patient numbers. That we have published all of the claims that have been made. because it’s very easy to say I’m doing a cannabis study. And there are two hundreds of those going on right now. I want to see that data published because that is what will push sort of ‘Cannabis 3.0’ in new countries. They can now say, ‘the data is there, the clinical trial has been done. And then we, Israel, will help to move cannabis forward everywhere.

MJNews:          And iCan, where will you be in 12 months from today? How many markets? You’ve got three aspects to your business. You’ve got the service aspect, the R & D; you’ve got the incubator; and you’ve got your CannaTech events. Where do you see the emphasis, for your company in the coming year?

Saul Kaye:         We, as a thesis, go after the emerging markets, so that’s why we’re going to [focus]. Panama, Latin America is forgotten with cannabis right now. There are 550 million people down there who will consume cannabis in the next year through legal channels. So Latin America is very important. Africa, CannaTech is going to go to Africa towards the end of 2019. Also, Africa is heating up and going to be a very interesting market. Both of those markets are driven by low-cost production of cannabis, which could decimate what’s going on around the world. That’s going to become very interesting to see how those new markets affect the more established markets. And we’ll be in Europe as well. So, you know, we’re staying out of the US right now — there’s a little too much noise in the conference space — and really focusing on the new emerging markets. So, we’ll be looking in Italy, in Europe, and somewhere in Africa and we’re about to be in Panama in February, which is going to be an awesome show. You should come down.

MJNews:          Fantastic. How do folks get ahold of you? And what are you looking for? You’re looking for investors. You’re looking for intellectual property. You’re looking for governments? Where’s your business development focus?

Saul Kaye:         Across all three. So, if you’d like to attend the CannaTech, or sponsor at CannaTech, let us know [website] that the, you know, usually goes through Joshua. If you have intellectual property or a company, or an idea that you’re looking to incubate in the cannabis space and it has an application for global effect — don’t come to me if you want to be a grower in Oregon, that’s not the type of deals we’re looking for — and obviously investors who want a pipeline of early stage companies that are going to disrupt this industry for the next very long time. Come to me. I’ve got an awesome portfolio of companies looking for support.

MJNews:          Fantastic. CEO/Founder Saul Kaye. thank you so much sir. I really appreciate your time.

Saul Kaye:         Thank you. Happy New Year.

 

New MJBA PSA Reminds Us: Everything Plastic Can Be Made From Hemp

NEVADA: The Marijuana Business Association (MJBA), a leading national cannabis business organization and publishers of this website, today launched a national PSA campaign to raise awareness among industry professionals of the many uses of hemp, particularly as an alternative to eco-unfriendly plastics.

Everything Plastic Grinder“Everything plastic can be made from hemp” reads the headline of the series — and images showcase some of the thousands of petrochemical-based products that can easily be made from hemp.  Striking photography features cannabis packaging items like the plastic doob tube and the mylar bag — ubiquitous scourges plaguing the newly-legal industry.

Everything Plastic Sunglasses

“Now that the Farm Bill has been signed, and hemp has been descheduled, it is time for the legal cannabis to take the lead in educating the public about the many benefits and innovations available with hemp,” said MJBA Founder/Executive director David Rheins. “As a first step, I’d like to see us reduce the use of mylar bags and plastic jars and doob tubes immediately — and begin incorporating hemp into our industry’s packaging.”

Everything Plastic 2

 

The PSA campaign, created in-house, will run on the MJNews Network and its vast social media network, as well as national distribution across Higher Ground, 420MEDIA and Marijuana Channel One.  Other networks are expected to pick up the campaign.

 

Everything Plastic jarNew creative iterations are expected to run throughout 2019, and plans call for television executions.  For more information about participating in MJBA’s PSA efforts, email us at: info@mjba.net

European-American Cannabis Business Conference Is Oct 5&6 In LA

CALIFORNIA: EuroAm CBC is a set of trade-oriented conferences focusing on closer cooperation and trade Exchange between Europe and America. Based upon the success of Cannafest Prague, the largest cannabis trade show in the world, organizers have decided to export the first American edition of the show, taking place in Los Angeles, October 5–6, 2018.

The pilot edition of this international conference was held straight before Cannafest Prague 2017, where it was very well received and the organizers now decided to bring it also to the American shores. “The main purpose of the conference is to connect the traditional European cannabis markets, where some companies have been active for more than thirty years, with emerging markets in America,” says Lukáš Běhal, the founder of the conference and CEO of Cannafest Prague.

EuroAm CBC L.A. 2018 is thematically divided into four sections focusing on Europe, the United States, Canada and South America, and will welcome world-known professionals, who will share their valuable insights into the world of cannabis business. You can look forward to presentations of David Rheins (MJBA), Vin Maru (Invest in MJ), Lukáš Běhal (Cannafest) and many others.

The conference will take place in the beautiful space of the Hollywood Roosevelt Hotel, situated in the heart of Hollywood, along the legendary Walk of Fame. Tickets for are now available in pre-sale.

EuroAm CBC LA is Oct 5&6

EuroAm CBC LA is Oct 5&6


EuroAm CBC L.A. 2018

October 5–6, 2018

Tickets: $200 – $399

Location: The Hollywood Roosevelt Hotel,

7000 Hollywood Boulevard, L.A, CA 90028

The Wink In Weed: The Road To Oklahoma Hempfest

By David Rheins 

OKLAHOMA: You know the winds of progress are blowing in your favor when you find yourself making plans to head to Oklahoma City for a cannabis festival.

The Road to Oklahoma Hempfest begins this weekend, as the first of three events heralding in a new era for the Sooner state.   A licensed and approved spinoff of Seattle Hempfest, The event will provide a forum and rallying point for participants in the nascent medical cannabis and industrial hemp communities;  a gathering place for sharing information, conducting education and coordinating efforts for the November elections, where adult-use cannabis is on the ballot.

Tickets are FREE to the historic event, which begins at 9am at the Sheraton Reed Convention center in Midwest city. Featured speakers at the Hemposium include many seminal figures — including Connie Johnson, Oklahoma State Senator and Cannabis Advocate, Seattle Hempfest’s Sharon Whitson and Vivian McPeak, Patrick Saint, Twenty22Many Foundation, and Grandma Cat Jeter. The Marijuana Business Association is proud media sponsor for Oklahoma Hempfest, and MJBA founder/executive director David Rheins is a featured speaker.

The Hemposium programming starts at 9AM and will go until 4PM.

  • Oklahoma Hempfest

Speakers List for “The Road to Hempfest”
Connie Johnson – Oklahoma State Senator and Cannabis Advocate
Terri Leek – CEO/Founder Pure Hemp Collective
Victoria Huggins – Studio 89 Massage – Advance Massage
Patrick Saint – Founder of Twenty22Many Foundation
Cat Jeter – Cannabis Activist centered on children
Vivian McPeak – Director of Seattle Hempfest
Sharon Whitson – Operating manager of Hempfest Central
Chad Bibler – Hemp advocate and social media activist called the Hemp Father
Timothy Edwards – Founder of Cannabis Saves Lives
David Rheins – Founder of Marijuana Business Association
Brandi Bibler – Hemp Advocate
Lenny Vanhorn – Comedian and Cannabis Activist
Rusty Shackelford – Cannabis Activist after injury
Mark Hubbard – Industrial Hemp Expert
Norma Sapp – Oklahoma NORML

Oklahoma native Scott McKinley — CEO of HiTunes and a longtime promoter at Seattle Hempfest, Cavi Gold and many other canna events — and his local partners have tapped into a lifetime of connections and personal contacts to make this historic series of events a reality.  In support from Seattle Hempfest, the team worked tirelessly to muster talent, sponsors, vendors and political support — in the midst of the legal wrangling around medical marijuana — needed to make this first Hempfest possible.  It wasn’t easy, and due to the magnitude and overwhelming response from the public, the organizers decided to move the initial main event date back to June 7th – 9th, 2019.

Why is this Hempfest such a big deal?  Oklahoma represents the bedrock of the conservative Midwest, and is culturally as far from the liberal West Coast as you can get.  When legal cannabis comes to Oklahoma, it has arrived in the front yard of middle America. We are witnessing the mainstreaming of marijuana in real time.

Legally, Oklahoma has never been a canna-friendly place, and even with the new medical cannabis laws passed this summer, and adult-use legalization on the November ballot, the Sooner State maintains some of the harshest penalties for possession, cultivation and sale on the books — especially when it comes to concentrates and hash. The War on Drugs remains very real here, and prohibition continues to ruin lives.

Oklahoma Cannabis Laws, according to NORML:

  • Possession of any amount of marijuana is a misdemeanor with a term of imprisonment of up to one year and a fine of up to $1,000
  • The sale of less than 25 pounds is a felony, punishable by incarceration for a period of 2 years-life, as well as a fine of $20,000.
  • Cultivating up to 1,000 plants is a felony, punishable by a maximum $25,000 fine and between 20 years and life imprisonment.
  • Cultivation of marijuana by the owner of land is a felony punishable by a term of imprisonment between 2 years and life and a fine up to 50,000.
  • Converting or attempting to convert marijuana into hashish or concentrates is a felony punishable by a fine no greater than $50,000 and a term of imprisonment no less than 2 and up to remainder of the offender’s life
  • Distributing, dispensing, transporting with intent to distribute, possessing with intent to manufacture, distribute, or dispense, hashish or concentrates is a felony punishable by a fine no greater than $20,000 and a term of imprisonment no less than 2 years and up to the remainder of the offender’s life.

Oklahoma’s Medical Marijuana Law:

  • Those possessing a state-issued license may possess the following: up to eight ounces of marijuana in their residence; up to one ounce of concentrated marijuana; up to 72 ounces of edible marijuana; up to six mature marijuana plants; up to six seedling plants; and up to three ounces of marijuana on their person. Those who do not possess a license face a fine-only misdemeanor for the possession of up to 1.5 ounces of herbal cannabis.

Demand for legal medical cannabis from the public has been strong, as more than 1,600 people and businesses applied for Oklahoma medical marijuana licenses on the first day that applications were made available, according to ABC News

Tickets to The Road To Oklahoma Hempfest are FREE, and available online.

 

 

 

The Wink In Weed: Lessons Learned At Seattle Hempfest

By David Rheins

I’m just back from another epic Seattle Hempfest.  The Pacific Northwest is one of the most beautiful regions on the planet, and its volcanic mountains, vibrant cities and evergreen forests never cease to inspire wonder.  I cherish my PNW canna-family, and am humbled at how rich and meaningful have been our shared experiences, as we workers in weed have toiled to reform marijuana law, and establish a legal cannabis industry.

Jake The Professor and Don Skakie talk Washington Homegrow

Jake The Professor and Don Skakie talk Washington Homegrow

It is a treat to spend time with legends: Farmer Tom Lauerman, Jake The Professor, Grandma Cat Jeter, Kevin and Crystal Oliver, AC Braddock and Fritz Chess, David Tran, Vivian McPeak, Joy Beckerman, Nurse Heather Manus, Ah Warner and so many others.  This year we were honored to have USVI Senator Positive Nelson, who was traveling with a video crew from 420MEDIA,  visit with us.  I first met Terence, who is universally known as ‘Positive’, at a High Tea at Seattle’s Green Labs Farms a few years back, when as moderator I had the privilege of introducing the pro-pot and “positive living” politician to the cannabis community.  Look for great things from the Senator and USVI (pot tourism anyone?) soon.

The canna family gathers every year at Hempfest

The canna family gathers every year at Hempfest

Seattle Hempfest for me has always seemed like the ‘State Fair of Weed.’  Tens of thousands of people — of every age, shape and size — streaming through a labyrinth of vendor booths, food trucks and tents, smoking weed, hanging out and listening to advocates preach to the choir, and bands sing about “Mary Jane.”  This year was no different, a little smaller — a couple fewer stages due to lack of sponsorship support — and smokier, as a result of raging fires in Canada and Eastern Washington.

2018-08-19 14.44.11

Eden Labs’ Fritz Chess, Flower Girls Queen MJ, and MJBA Ambassador At Large Jake The Professor

At the Curved Papers/MJBA booth, and at a series of industry parties, I had the opportunity to reconnect to my industry friends and colleagues. What I heard was a consistent narrative: these are make or break times for Washington licensees.  Competition is fierce and getting fiercer.  Wholesale prices are brutally low for producers, and while sales remain strong at retail and gross revenues are high, profits are elusive and unfair taxes still eat up most of the profits.  For licensees the choice is straightforward: differentiate or die.

Much of our conversation revolved around the mainstreaming of cannabis — and the impact that the $4B USD investment that Constellation Brands just made with Canopy Growth would have on the mom & pops. The game has gone from grassroots to international overnight, and for the smaller players there is tremendous pressure to scale.  Undercapitalized businesses are putting their licenses up for sale, or looking for partnerships and mergers.

 

DOPE celebrated its 7th Anniversary with a “Golden Ticket” Party

Cannafest Destiny.  The West Coast is the fertile birthplace of the legal cannabis industry.  While NORML, established in 1970, can rightfully claim authorship of the political legalization and reform movement, the business — and more importantly the community — started in California, Oregon, Washington (and British Columbia).   The legitimate markets that we have created out West have blazed bright, sparks have now inspired entrepreneurs, activists, investors and politicians across the country — from Maine to Maryland, Michigan to Oklahoma. Our duty and opportunity is now to export the incredible experience and knowledge to these new emerging markets.

In a weird wrinkle of federal prohibition, Legal Cannabis has become international, before it has become a national industry!  Our neighbors to the north are rapidly ramping up their legal cannabis industry, and positioning themselves globally with distribution deals in emerging European, Caribbean and South American markets. Public Canadian companies are gobbling up American brands, and deals are now measured in the billions.

Jeremy MIller is organizing Viva Las Hempfest!

Jeremy Miller is organizing Viva Las Hempfest!

No where can we witness the mainstreaming of marijuana better than Las Vegas.  Neon billboards on strip.  24/7 retailers with drive thru.  Las Vegas, once upon a time among the harshest places in America to be caught with a seed or a stem (an infraction that could land you 20 years in the hoosegow) now actively planning the opening of consumption lounges and canna-friendly hotels.  No peace, love and tie dye hippie culture here.  Just the business of entertainment.  It is fitting then that the next stop for the Cannafest Destiny tour will be Las Vegas Hempfest on November 3&4th — Viva Las Hempfest! Hope to see you there!

The Wink In Weed: Why Seattle Hempfest Is Still Worth Supporting

By David Rheins

It’s been five years since Washington opened its legal cannabis marketplace, and today adult consumers in the Evergreen state have an abundance of high-quality, legal weed available in an impressive array of product configurations at affordable prices.

Seattle Hempfest, taking place this week along the gorgeous Puget Sound, is the nation’s oldest and largest “Protestival.”  It began as forum and platform for activists, patients and pot smokers to gather together to fight for their rights to toke in peace.  Back then, firing up a joint in public had real potential consequences — and could land you with a fine or even jail time.

My fellow Hempfest Volunteers in their Green T-Shirts

Hempfest Volunteers

Today, Washingtonians don’t have to go to the park to spark up. Pot smoking is legal, accepted and somewhat normalized in the Pacific Northwest. Leading some to ask what is the relevance of Seattle Hempfest?

While more of a party these days than a protestival, Seattle Hempfest is still a must-attend annual gathering of the cannabis tribes.  Our Green Revolution is a broad tent, with a diverse set of communities.  We are advocates, patients, farmers, business professionals, parents, teachers and caregivers, all united under the belief that Federal Prohibition, and the War on Drugs — and Drugs Users — must end. There is something powerful and undeniable about seeing a hundred thousand pot smokers gather together to celebrate community.

There is still much legal reform that needs to happen before cannabis consumption is fully normalized — and it is encouraging to see the momentum behind the STATES ACT and the Marijuana Justice Act as Congress has finally gotten the word that the American public — on both sides of the aisle — are through with prohibition.  The 2018 Farm Bill, with its Hemp Farming provision, will de-schedule industrial hemp and open the way for explosive growth in hemp-based products, including consumer goods, industrial materials, foods, fuels and medicines.

We are in a fight for the control of our legal cannabis industry.  Big Pharma, Big Alcohol, Big Tobacco, Big Agriculture and Big Government Regulators are all fighting to establish their places in our new mainstream marijuana marketplace. We must continue to stay involved now as the new regulations and standards of our emerging industry are crafted. I see Hempfest as a natural venue for showcasing the best and most innovative hemp products. Cannabis consumer rights need to be protected to ensure that the legal products are safe, tested and of the highest quality. Legal cannabis businesses have an opportunity to build an industry based on the highest standards of production, marketing and operations.  We need to be fair and equitable in our hiring and compensation practices, and we need to direct the windfall of new marijuana tax revenues towards improving the health and welfare of local communities, particularly those hit hard from the War On Drugs.

CurvedPapersHempfest512x440As our alternative culture takes centerstage, it is important that we stand together for our shared values.  We are witnessing and influencing the end of an era. The post-WWII, better living thru petrochemicals, conspicuous consumption society is unsustainable — and is quickly being replaced by a global, plant-based lifestyle, renewable energy zeitgeist.

MJBA is proud to once again participate as a media sponsor and exhibitor of Seattle Hempfest.  We’re thrilled to be sharing a booth with Curved Papers, with whom we’ve been touring the country on a Cannafest Destiny Tour.  We’ll be showing off our NORML 100% Hemp rolling papers, and showcasing our latest poster by Michael Guttsen, and doing social media blasts with MJBA Ambassador At Large Jake Dimmock.  Please join us at Booth #323 across from the Hemposium.

Michael O'Malley, David Hynes Michael O'Malley David Rheins

It has never been more important to stand up and be counted.  Please come out to Myrtle Edwards park this weekend, listen to the speakers, dance to the music and support the many food and merchandise vendors.  Be sure to drop a few bucks in the donation bucket:  Seattle Hempfest is an all-volunteer effort, and it depends on the support of its Vendors, Sponsors and Attendees to survive.

 

 

Marijuana Business Association Is Media Sponsor Of First Oklahoma Hempfest

MJBA Founder David Rheins Is Featured Speaker At Historic Hemp Festival

WASHINGTON: The first Oklahoma Hempfest  is shaping up to be enormous. Promoter Scott McKinley has assembled a world-class lineup of major talent for the FREE event, including DJ Snoopadelic (Snoop Dogg), Kokane, GapX The Band, Twista, Ryan Upchurch “The Redneck” and many more, and has now enlisted the support of the Marijuana Business Association, and its founder David Rheins, the cannabis industry’s unofficial business ambassador.

2018-Generic-Badge-RWB

MJBA Is A Proud Sponsor of Oklahoma Hempfest Sept 7-9th

MJBA, which publishes the popular MJ News Network — The Voice of Legal Cannabis — whose properties include MJ Headline News on Facebook and Marijuana Channel One on YouTube, will serve as media sponsor for Oklahoma Hempfest bringing to bear the resources of its more than 300,000 subscribers to promote the event.  MJ Headline News and MJ Channel One will field reporting teams on site to provide live coverage and conduct exclusive interviews with event speakers, performers and VIPs.  Rheins, a renowned expert in media, marketing and branding, will address the opportunity that awaits Oklahoma’s nascent legal cannabis community.

“The MJBA has been a staple in our industry. It’s Executive Director David Rheins has traveled to each legal market speaking to each community about the new growth and challenges of our emerging market,” McKinley told MJNN. “From his background as President of the trendsetting Spin Magazine, to his groundbreaking work in the digital media space, David definitely understands the dynamics of a developing market and its growing pains. We are very excited to have the MJBA team on board with Oklahoma Hempfest — bringing this knowledge to Oklahoma is paramount.”

I’m thrilled to be a part of this historic hemp festival,” said David Rheins. “MJBA has long been a supporter of Seattle Hempfest, and it is an honor to open yet another legal cannabis marketplace. Oklahoma has passed medical marijuana, and it looks like the voters will demand adult-use cannabis as well this November. Scott and his team have brilliantly created this free event as a rallying point, and Oklahoma Hempfest will be a ground zero mobilization point for the legalization and cannabis communities just prior to the important elections.”